Quark Venture
Finance · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1075 W Georgia St 2500, Vancouver, Briti...Phone Number
(604) 262-8818Website
www.quarkventure.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Quark Venture
Quark Venture LP is a venture capital company focused on equity financing of innovative biotechnology companies with breakthrough technology platforms. The company's strategic goal is to continually support such entrepreneurial biotechnology companies to efficiently improve the technology platform and obtain high-growth value by providing diversified healthcare products or services. Quark's proven success is achieved through long-term relationships with target companies that share similar technology innovation visions.Explore more
Quark Venture Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Quark Venture your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Quark Venture recently announced quarterly report
Website visits: Recent activity has been detected on your website
Quark Venture, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Quark Venture
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Quark Venture launches new products
Click to see if Quark Venture had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Quark Venture has new funding data
Check out if Quark Venture is spiking on competitors!
Check if Quark Venture has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Quark Venture
Find more new buyers
Compare Similar Companies to Quark Venture
Compare insights from companies similar to Quark Venture, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Quark Venture is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Quark Venture is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Quark Venture.
Quark Venture Tech Stack
A closer look at the technologies used by Quark Venture
See more technologies
Most Recent Scoops
Facilities Relocation / Expansion
Quark Venture is planning to move its offices in January 2022. The move will impact approximately 35 employees at their existing office located at #2500-1075 West Georgia St., Vancouver, BC.
Facilities Relocation/Expansion
Project
Spending/Investment
Project
Spending/Investment
Project
Quark Venture News & Media
Global Health Sciences Fund (Quark Venture LP and GF Securities) Participates in $25 Million Financing for EyeYon Medical’s EndoArt® Clinical Trials Across Three Continents
VANCOUVER, British Columbia, March 15, 2021 (GLOBE NEWSWIRE) -- Quark Venture LP (Quark) and GF Securities participated in the $25 million financing of EyeYon Medical, to advance its EndoArt® clinical trials. This investment, made through the Global Health Sciences (GHS) fund, was led by a global ophthalmology industry leader and CRCP alongside new and existing shareholders BPC, Diamond BioFund, Rimonci, Pontifax and Triventures.Global Health Sciences Fund (Quark Venture LP and GF Securities) Announces Portfolio Company SQZ Biotechnologies’ IPO
VANCOUVER, British Columbia, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Quark Venture LP (Quark) and GF Securities are pleased to announce the successful listing of portfolio company, SQZ Biotechnologies (NYSE: SQZ) (“SQZ”) on the New York Stock Exchange (NYSE) as of October 30, 2020. This announcement marks Global Health Sciences (GHS) Fund’s third portfolio company to successfully go public after Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) in April 2018 and Keros Therapeutics, Inc. (NASDAQ: KROS) in ApV-Wave Completes Financing of Up to $98M from Syndicate of Leading Global Healthcare Investors
CAESAREA, Israel and AGOURA HILLS, Calif., Sept. 22, 2020 /PRNewswire/ -- V-Wave Ltd., a cardiovascular device company developing proprietary, minimally invasive interatrial shunt devices for treating patients with severe symptomatic heart failure (HF) and pulmonary arterial hypertension...ARTMS Closes a US$19 Million Series A Financing with Deerfield and Global Health Sciences (GHS) Fund
VANCOUVER and NEW YORK, May 20, 2020 /PRNewswire/ - ARTMS Inc. a global leader in developing technology that transforms the production of the world's most-used diagnostic imaging isotopes, today announced that it has raised US$19 million in a Series A financing. The investment was led by...
Read more news
Top Finance Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Quark Venture
Sign Up For FreeTo access detailed company insights
Quark Venture LP is a venture capital company focused on equity financing of innovative biotechnology companies with breakthrough technology platforms. The company's strategic goal is to continually support such entrepreneurial biotechnology companies to efficiently improve the technology platform and obtain high-growth value by providing diversifi... Read More
